Author

S. Nimmagadda

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Organism:human· 1 Assay:imaging· 1 Research Focus:perturbation response prediction· 1 Organism:zebrafish· 1

Frequent Co-Authors

A. Calof· 1 shared A. D. Lander· 1 shared A. K. Sharma· 1 shared A. Mishra· 1 shared A. v. Sharrock· 1 shared C. B. Gocke· 1 shared D. Ding· 1 shared D. F. Ackerley· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Calof

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Gallium-68-Labeled Peptide Radiotracer For CD38-Targeted Imaging In Multiple Myeloma With PET

A. K. Sharma, K. Gupta, A. Mishra, G. Lofland, I. Marsh, D. Kumar, G. Ghiaur, P. Imus, R. F. Hobbs, C. B. Gocke, S. Nimmagadda

This paper develops a gallium-68-labeled peptide radiotracer, [68Ga]Ga-AJ206, for non-invasive CD38 imaging in multiple myeloma using PET, showing high specificity and utility in monitoring therapy response.

bioRxiv · May 9, 2023 · PreprintCancer Biology

NTR 2.0: a rationally-engineered prodrug converting enzyme with substantially enhanced efficacy for targeted cell ablation

A. v. Sharrock, T. S. Mulligan, K. R. Hall, E. M. Williams, D. T. White, L. Zhang, F. Matthews, S. Nimmagadda, S. Washington, K. Le, D. Meir-Levi, O. L. Cox, M. T. Saxena, A. Calof, M. E. Lopez-Burks, , J. S. Mumm

This paper describes the development of NTR 2.0, a modified nitroreductase with significantly improved efficacy for targeted cell ablation using metronidazole.

bioRxiv · May 22, 2020Cell Biology